Levocarnitine
11 NDCs across 4 manufacturers|6 Generic,5 Brand
Levocarnitine is used to treat deficiency diseases, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 27, 1985, and the first generic was approved Mar 29, 2001. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Levocarnitine across 39,000 claims for 5,860 beneficiaries.
Levocarnitine is available as 11 NDCs from 4 manufacturers (6 generic, 5 brand), with NADAC prices from $0.14 to $0.54 per ML — the most expensive product costs about 3.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
6G / 5B
Manufacturers
4
competing in market
Price Spread
$0.14 – $0.54
per ML, 8 of 11 NDCs
7d Activity
avg +2.8% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing LEVOCARNITINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARNITOR 330 MG TABLET | $1.2272 per EA | — |
LEVOCARNITINE 330 MG TABLET | $0.6612 per EA | +1.89% |
LEVOCARNITINE 330 MG TABLET | $0.6612 per EA | +1.89% |
CARNITOR SF 1 GM/10 ML SOLN | $0.5357 per ML | — |
CARNITOR SF 1 GM/10 ML SOLN | $0.5357 per ML | — |
CARNITOR 1 GM/10 ML ORAL SOLN | $0.4416 per ML | — |
CARNITOR 100 MG/ML ORAL SOLN | $0.3397 per ML | — |
LEVOCARNITINE SF 1 G/10 ML SOL | $0.2537 per ML | -0.19% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1387 per ML | +4.38% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1387 per ML | +4.38% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1387 per ML | +4.38% |
Frequently Asked Questions
What is Levocarnitine used to treat?
Levocarnitine is used to treat deficiency diseases, per the National Library of Medicine's MED-RT classification.
When did Levocarnitine become available as a generic?
FDA approved the first generic Levocarnitine (ANDA) on Mar 29, 2001. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Levocarnitine?
In 2024, Medicare Part D spent $4 million on Levocarnitine across 39,000 claims for 5,860 beneficiaries.
How many Levocarnitine products are on the market?
The Levocarnitine drug market contains 11 NDCs from 4 manufacturers — 6 generic and 5 brand products.
What is the price range for Levocarnitine?
NADAC reference prices for Levocarnitine range from $0.1387 to $0.5357 per ML — the most expensive product costs about 3.9× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Levocarnitine cheaper than brand?
The average generic NADAC for Levocarnitine is $0.1674 per ML, versus $0.4632 for brand-labeled products — brand versions average about 2.8× the generic price.
Which manufacturers make Levocarnitine?
4 manufacturers list Levocarnitine in NADAC. Ranked by number of NDCs, the largest are Leadiant Biosciences, Inc. (5), ANI Pharmaceuticals, Inc. (3), Rising Pharma Holdings Inc. (2), TruPharma LLC (1).
How has the price of Levocarnitine changed recently?
Over the past 7 days, 5 Levocarnitine NDCs rose and 1 fell, with a market-wide average change of +2.8%.